Cargando…
Transdifferentiating Astrocytes Into Neurons Using ASCL1 Functionalized With a Novel Intracellular Protein Delivery Technology
Cellular transdifferentiation changes mature cells from one phenotype into another by altering their gene expression patterns. Manipulating expression of transcription factors, proteins that bind to DNA promoter regions, regulates the levels of key developmental genes. Viral delivery of transcriptio...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258721/ https://www.ncbi.nlm.nih.gov/pubmed/30525033 http://dx.doi.org/10.3389/fbioe.2018.00173 |
_version_ | 1783374542919434240 |
---|---|
author | Robinson, Meghan Fraser, Ian McKee, Emily Scheck, Kali Chang, Lillian Willerth, Stephanie M. |
author_facet | Robinson, Meghan Fraser, Ian McKee, Emily Scheck, Kali Chang, Lillian Willerth, Stephanie M. |
author_sort | Robinson, Meghan |
collection | PubMed |
description | Cellular transdifferentiation changes mature cells from one phenotype into another by altering their gene expression patterns. Manipulating expression of transcription factors, proteins that bind to DNA promoter regions, regulates the levels of key developmental genes. Viral delivery of transcription factors can efficiently reprogram somatic cells, but this method possesses undesirable side effects, including mutations leading to oncogenesis. Using protein transduction domains (PTDs) fused to transcription factors to deliver exogenous transcription factors serves as an alternative strategy that avoids the issues associated with DNA integration into the host genome. However, lysosomal degradation and inefficient nuclear localization pose significant barriers when performing PTD-mediated reprogramming. Here, we investigate a novel PTD by placing a secretion signal sequence next to a cleavage inhibition sequence at the end of the target transcription factor–achaete scute homolog 1 (ASCL1), a powerful regulator of neurogenesis, resulting in superior stability and nuclear localization. A fusion protein consisting of the amino acid sequence of ASCL1 transcription factor with this novel PTD added can transdifferentiate cerebral cortex astrocytes into neurons. Additionally, we show that the synergistic action of certain small molecules improves the efficiency of the transdifferentiation process. This study serves as the first step toward developing a clinically relevant in vivo transdifferentiation strategy for converting astrocytes into neurons. |
format | Online Article Text |
id | pubmed-6258721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62587212018-12-06 Transdifferentiating Astrocytes Into Neurons Using ASCL1 Functionalized With a Novel Intracellular Protein Delivery Technology Robinson, Meghan Fraser, Ian McKee, Emily Scheck, Kali Chang, Lillian Willerth, Stephanie M. Front Bioeng Biotechnol Bioengineering and Biotechnology Cellular transdifferentiation changes mature cells from one phenotype into another by altering their gene expression patterns. Manipulating expression of transcription factors, proteins that bind to DNA promoter regions, regulates the levels of key developmental genes. Viral delivery of transcription factors can efficiently reprogram somatic cells, but this method possesses undesirable side effects, including mutations leading to oncogenesis. Using protein transduction domains (PTDs) fused to transcription factors to deliver exogenous transcription factors serves as an alternative strategy that avoids the issues associated with DNA integration into the host genome. However, lysosomal degradation and inefficient nuclear localization pose significant barriers when performing PTD-mediated reprogramming. Here, we investigate a novel PTD by placing a secretion signal sequence next to a cleavage inhibition sequence at the end of the target transcription factor–achaete scute homolog 1 (ASCL1), a powerful regulator of neurogenesis, resulting in superior stability and nuclear localization. A fusion protein consisting of the amino acid sequence of ASCL1 transcription factor with this novel PTD added can transdifferentiate cerebral cortex astrocytes into neurons. Additionally, we show that the synergistic action of certain small molecules improves the efficiency of the transdifferentiation process. This study serves as the first step toward developing a clinically relevant in vivo transdifferentiation strategy for converting astrocytes into neurons. Frontiers Media S.A. 2018-11-21 /pmc/articles/PMC6258721/ /pubmed/30525033 http://dx.doi.org/10.3389/fbioe.2018.00173 Text en Copyright © 2018 Robinson, Fraser, McKee, Scheck, Chang and Willerth. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Robinson, Meghan Fraser, Ian McKee, Emily Scheck, Kali Chang, Lillian Willerth, Stephanie M. Transdifferentiating Astrocytes Into Neurons Using ASCL1 Functionalized With a Novel Intracellular Protein Delivery Technology |
title | Transdifferentiating Astrocytes Into Neurons Using ASCL1 Functionalized With a Novel Intracellular Protein Delivery Technology |
title_full | Transdifferentiating Astrocytes Into Neurons Using ASCL1 Functionalized With a Novel Intracellular Protein Delivery Technology |
title_fullStr | Transdifferentiating Astrocytes Into Neurons Using ASCL1 Functionalized With a Novel Intracellular Protein Delivery Technology |
title_full_unstemmed | Transdifferentiating Astrocytes Into Neurons Using ASCL1 Functionalized With a Novel Intracellular Protein Delivery Technology |
title_short | Transdifferentiating Astrocytes Into Neurons Using ASCL1 Functionalized With a Novel Intracellular Protein Delivery Technology |
title_sort | transdifferentiating astrocytes into neurons using ascl1 functionalized with a novel intracellular protein delivery technology |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258721/ https://www.ncbi.nlm.nih.gov/pubmed/30525033 http://dx.doi.org/10.3389/fbioe.2018.00173 |
work_keys_str_mv | AT robinsonmeghan transdifferentiatingastrocytesintoneuronsusingascl1functionalizedwithanovelintracellularproteindeliverytechnology AT fraserian transdifferentiatingastrocytesintoneuronsusingascl1functionalizedwithanovelintracellularproteindeliverytechnology AT mckeeemily transdifferentiatingastrocytesintoneuronsusingascl1functionalizedwithanovelintracellularproteindeliverytechnology AT scheckkali transdifferentiatingastrocytesintoneuronsusingascl1functionalizedwithanovelintracellularproteindeliverytechnology AT changlillian transdifferentiatingastrocytesintoneuronsusingascl1functionalizedwithanovelintracellularproteindeliverytechnology AT willerthstephaniem transdifferentiatingastrocytesintoneuronsusingascl1functionalizedwithanovelintracellularproteindeliverytechnology |